{"url_path":"/sec/cero/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1870404/0001213900-26-057753-index.html","accession_number":"0001213900-26-057753","cik":"0001870404","ticker":"CERO","issuer_name":"CERO THERAPEUTICS HOLDINGS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1870404/0001213900-26-057753-index.html","primary_entity_key":"0001870404","primary_entity_name":"CERO THERAPEUTICS HOLDINGS, INC."},"word_count":2103,"has_tables":true,"body_markdown":"**Item\n6. Exhibits**\n\n \n\nThe\nfollowing exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.\n\n \n\n**No.**\n \n**Description\nof Exhibit**\n\n**Exhibit No.**\n \n**Description**\n\n \n \n \n\n3.1\n \n[Second\nAmended and Restated Certificate of Incorporation of CERo Therapeutics Holdings, Inc. (incorporated by reference to Exhibit 3.1 to\nthe Current Report on Form 8-K/A filed by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on February\n27, 2024).](http://www.sec.gov/Archives/edgar/data/1870404/000121390024017157/ea193847ex3-1_cerothera.htm)\n\n \n \n \n\n3.2\n \n[Second\nAmended and Restated Bylaws of CERo Therapeutics Holdings, Inc. (incorporated by reference to Exhibit 3.2 to the Current Report on\nForm 8-K/A filed by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on February 27, 2024).](http://www.sec.gov/Archives/edgar/data/1870404/000121390024017157/ea193847ex3-2_cerothera.htm)\n\n \n \n \n\n3.3\n \n[Certificate\nof Designation of Preferences, Rights and Limitations of the Series A Convertible Preferred Stock (incorporated by reference to Exhibit\n3.3 to the Current Report on Form 8-K/A filed by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on\nFebruary 27, 2024).](http://www.sec.gov/Archives/edgar/data/1870404/000121390024017157/ea193847ex3-3_cerothera.htm)\n\n \n \n \n\n3.4\n \n[Certificate\nof Correction to Certificate of Designation of Preferences, Rights and Limitations of the Series A Convertible Preferred Stock (incorporated\nby reference to Exhibit 3.4 to the Current Report on Form 8-K/A filed by CERo Therapeutics Holdings, Inc. with the Securities and\nExchange Commission on February 27, 2024).](http://www.sec.gov/Archives/edgar/data/1870404/000121390024017157/ea193847ex3-4_cerothera.htm)\n\n \n \n \n\n3.5\n \n[Second\nCertificate of Correction to Certificate of Designation of Preferences, Rights and Limitations of the Series A Convertible Preferred\nStock (incorporated by reference to Exhibit 3.5 to the Current Report on Form 8-K/A filed by CERo Therapeutics Holdings, Inc. with\nthe Securities and Exchange Commission on February 27, 2024).](http://www.sec.gov/Archives/edgar/data/1870404/000121390024017157/ea193847ex3-5_cerothera.htm)\n\n \n \n \n\n3.6\n \n[Certificate\nof Designation of Preferences, Rights and Limitations of the Series B Convertible Preferred Stock (incorporated by reference to Exhibit\n3.6 to the Annual Report on Form 10-K filed by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on April\n2, 2024).](http://www.sec.gov/Archives/edgar/data/1870404/000121390024029051/ea020195501ex3-6_cerothera.htm)\n\n \n \n \n\n3.7\n \n[Certificate\nof Designation of Preferences, Rights and Limitations of the Series C Convertible Preferred Stock (incorporated by reference to Exhibit\n3.1 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on October\n2, 2024).](http://www.sec.gov/Archives/edgar/data/1870404/000121390024084200/ea021621601ex3-1_cerothera.htm)\n\n \n \n \n\n3.8†\n \n[Certificate\nof Designation of Preferences, Rights and Limitations of the Series D Convertible Preferred Stock (incorporated by reference to Exhibit\n3.1 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on April\n25, 2025).](http://www.sec.gov/Archives/edgar/data/1870404/000121390025035535/ea023932101ex3-1_cero.htm)\n\n \n \n \n\n3.9\n \n[Certificate\nof Amendment to the Second Amended and Restated Certificate of Incorporation of CERo Therapeutics Holdings, Inc. (incorporated by\nreference to Exhibit 3.1 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities and Exchange\nCommission on June 11, 2025).](http://www.sec.gov/Archives/edgar/data/1870404/000121390025053292/ea024532801ex3-1_cero.htm)\n\n \n \n \n\n3.10†\n \n[Certificate\nof Designation of Preferences, Rights and Limitations of the Series E Convertible Preferred Stock (incorporated by reference to Exhibit\n3.1 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on October\n14, 2025).](http://www.sec.gov/Archives/edgar/data/1870404/000121390025098421/ea026031801ex3-1_cero.htm)\n\n \n\n43\n\n \n\n4.1\n \n[Warrant\nAgreement, by and between Phoenix Biotech Acquisition Corp. and Continental Stock Transfer & Trust Company, dated October 5,\n2021 (incorporated by reference to Exhibit 4.4 to the Registration Statement on Form S-1 filed by Phoenix Biotech Acquisition Corp.\nwith the Securities and Exchange Commission on September 13, 2021).](http://www.sec.gov/Archives/edgar/data/1870404/000119312521271453/d198272dex44.htm)\n\n \n \n \n\n4.2\n \n[Form\nof Common Warrant (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K/A filed by CERo Therapeutics Holdings,\nInc. with the Securities and Exchange Commission on February 27, 2024).](http://www.sec.gov/Archives/edgar/data/1870404/000121390024017157/ea193847ex4-2_cerothera.htm)\n\n \n \n \n\n4.3\n \n[Form\nof Preferred Warrant (incorporated by reference to Exhibit 4.3 to the Current Report on Form 8-K/A filed by CERo Therapeutics Holdings,\nInc. with the Securities and Exchange Commission on February 27, 2024).](http://www.sec.gov/Archives/edgar/data/1870404/000121390024017157/ea193847ex4-3_cerothera.htm)\n\n \n \n \n\n4.4\n \n[Form\nof Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc.\nwith the Securities and Exchange Commission on September 25, 2024).](http://www.sec.gov/Archives/edgar/data/1870404/000121390024081792/ea021534601ex4-1_cerothera.htm)\n\n \n \n \n\n4.5\n \n[Form\nof Common Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings,\nInc. with the Securities and Exchange Commission on February 6, 2025).](http://www.sec.gov/Archives/edgar/data/1870404/000121390025010731/ea023015801ex4-1_cerotherap.htm)\n\n \n \n \n\n4.6\n \n[Form\nof Pre-Funded Warrant (incorporated by reference to Exhibit 4.8 to the Registration Statement on Form S-1/A filed by CERo Therapeutics\nHoldings, Inc. with the Securities and Exchange Commission on January 21, 2025).](http://www.sec.gov/Archives/edgar/data/1870404/000121390025004742/ea022697001ex4-8_cero.htm)\n\n \n \n \n\n4.7\n \n[Form\nof Note (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc.\nwith the Securities and Exchange Commission on February 13, 2026).](http://www.sec.gov/Archives/edgar/data/1870404/000121390026016474/ea027698401ex4-1_cero.htm)\n\n \n \n \n\n31.1*\n \n[Certification\nof Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant\nto Section 302 of the Sarbanes-Oxley Act of 2002.](ea029030001ex31-1.htm)\n\n \n \n \n\n31.2*\n \n[Certification\nof Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant\nto Section 302 of the Sarbanes-Oxley Act of 2002.](ea029030001ex31-2.htm)\n\n \n \n \n\n32.1#\n \n[Certification\nof Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of\n2022.](ea029030001ex32-1.htm)\n\n \n \n \n\n32.2#\n \n[Certification\nof Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of\n2022.](ea029030001ex32-2.htm)\n\n \n \n \n\n101.INS\n \nInline\nXBRL Instance Document (embedded within the Inline XBRL document).\n\n \n \n \n\n101.SCH\n \nInline\nXBRL Taxonomy Extension Schema Document.\n\n \n \n \n\n101.CAL\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document.\n\n \n \n \n\n101.DEF\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document.\n\n \n \n \n\n101.LAB\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document.\n\n \n \n \n\n101.PRE\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document.\n\n \n \n \n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n*\nFiled\nherewith.\n\n+\nIndicates\nmanagement contract or compensatory plan.\n\n#\nThe\ncertifications furnished in Exhibit 32.1 hereto are deemed to accompany this report and will not be deemed “filed” for\npurposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings\nunder the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.\n\n \n\n44\n\n \n\n**SIGNATURES**\n\n \n\nIn\naccordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned,\nthereunto duly authorized.\n\n \n\n \n**CERO THERAPEUTICS HOLDINGS, INC.**\n\n \n \n \n\nDate: May 15, 2026\nBy:\n/s/ Chris\nEhrlich\n\n \nName: \nChris Ehrlich\n\n \nTitle:\nChairman and Chief Executive Officer\n\n \n \n(Principal Executive Officer)\n\n \n \n \n\nDate: May 15, 2026\nBy:\n/s/ Andrew\nKucharchuk\n\n \nName:\nAndrew Kucharchuk\n\n \nTitle:\nChief Financial Officer\n\n \n \n(Principal Financial and Accounting Officer)\n\n \n\n \n\n45\n\n \n\nNONE\nNONE\n\nhttp://fasb.org/srt/2026#ChiefExecutiveOfficerMember\n1\n1\n\n0001870404\nfalse\nQ1\n--12-31\n\n0001870404\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:CommonStockParValue00001PerShareMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:WarrantsToPurchaseOneShareOfCommonStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\n2026-05-14\n\n0001870404\n\n2026-03-31\n\n0001870404\n\n2025-12-31\n\n0001870404\n\ncero:SeriesCConvertiblePreferredStockMember\n\n2026-03-31\n\n0001870404\n\ncero:SeriesCConvertiblePreferredStockMember\n\n2025-12-31\n\n0001870404\n\ncero:SeriesDConvertiblePreferredStockMember\n\n2026-03-31\n\n0001870404\n\ncero:SeriesDConvertiblePreferredStockMember\n\n2025-12-31\n\n0001870404\n\ncero:SeriesEConvertiblePreferredStockMember\n\n2026-03-31\n\n0001870404\n\ncero:SeriesEConvertiblePreferredStockMember\n\n2025-12-31\n\n0001870404\n\ncero:SeriesAConvertiblePreferredStockMember\n\n2026-03-31\n\n0001870404\n\ncero:SeriesAConvertiblePreferredStockMember\n\n2025-12-31\n\n0001870404\n\nus-gaap:CommonClassAMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:CommonClassAMember\n\n2025-12-31\n\n0001870404\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-12-31\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-12-31\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-12-31\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-12-31\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-12-31\n\n0001870404\n\ncero:SeriesACommonStockMember\n\n2025-12-31\n\n0001870404\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-12-31\n\n0001870404\n\nus-gaap:ReceivablesFromStockholderMember\n\n2025-12-31\n\n0001870404\n\nus-gaap:RetainedEarningsMember\n\n2025-12-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:SeriesACommonStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:ReceivablesFromStockholderMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:RetainedEarningsMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2026-03-31\n\n0001870404\n\ncero:SeriesACommonStockMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:ReceivablesFromStockholderMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:RetainedEarningsMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2024-12-31\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2024-12-31\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2024-12-31\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2024-12-31\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2024-12-31\n\n0001870404\n\ncero:SeriesACommonStockMember\n\n2024-12-31\n\n0001870404\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-12-31\n\n0001870404\n\nus-gaap:ReceivablesFromStockholderMember\n\n2024-12-31\n\n0001870404\n\nus-gaap:RetainedEarningsMember\n\n2024-12-31\n\n0001870404\n\n2024-12-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\ncero:SeriesACommonStockMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:ReceivablesFromStockholderMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:RetainedEarningsMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\ncero:ConvertiblePreferredStocksMember\n\n2025-03-31\n\n0001870404\n\ncero:SeriesACommonStockMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:ReceivablesFromStockholderMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:RetainedEarningsMember\n\n2025-03-31\n\n0001870404\n\n2025-03-31\n\n0001870404\n\ncero:SuccessorMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:SuccessorMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\ncero:SuccessorMember\n\n2025-12-31\n\n0001870404\n\ncero:SuccessorMember\n\n2024-12-31\n\n0001870404\n\ncero:SuccessorMember\n\n2026-03-31\n\n0001870404\n\ncero:SuccessorMember\n\n2025-03-31\n\n0001870404\n\nsrt:MinimumMember\n\n2026-03-31\n\n0001870404\n\nsrt:MaximumMember\n\n2026-03-31\n\n0001870404\n\n2024-02-29\n\n0001870404\n\nus-gaap:CommonStockMember\n\n2024-02-29\n2024-02-29\n\n0001870404\n\n2024-02-29\n2024-02-29\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\n\n2024-02-29\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\n\n2024-02-29\n2024-02-29\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\n\n2025-12-31\n\n0001870404\n\n2025-01-01\n2025-12-31\n\n0001870404\n\ncero:MonteCarloMember\n\n2026-03-31\n\n0001870404\n\ncero:MonteCarloMember\n\n2025-12-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel1Member\n\n2026-03-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel2Member\n\n2026-03-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel3Member\n\n2026-03-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel1Member\n\n2025-12-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel2Member\n\n2025-12-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel3Member\n\n2025-12-31\n\n0001870404\n\ncero:PredecessorMember\n\n2025-12-31\n\n0001870404\n\ncero:PredecessorMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:ConversionOfConvertiblePreferredStockIssuedAndOutstandingMember\ncero:SuccessorMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:ConversionOfConvertiblePreferredStockIssuedAndOutstandingMember\ncero:SuccessorMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\ncero:ConversionOfConvertibleNotesPayablesMember\ncero:SuccessorMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:ConversionOfConvertibleNotesPayablesMember\ncero:SuccessorMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\ncero:ExerciseOfCommonWarrantsIntoCommonStockMember\ncero:SuccessorMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:ExerciseOfCommonWarrantsIntoCommonStockMember\ncero:SuccessorMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\ncero:CommonStockUnderlyingOutstandingOptionsMember\ncero:SuccessorMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:CommonStockUnderlyingOutstandingOptionsMember\ncero:SuccessorMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\n2026-02-09\n\n0001870404\n\n2026-02-09\n2026-02-09\n\n0001870404\n\n2026-03-06\n2026-03-06\n\n0001870404\n\n2026-03-06\n\n0001870404\n\nus-gaap:MeasurementInputExpectedDividendRateMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:MeasurementInputExpectedTermMember\n\n2026-03-31\n\n0001870404\n\nsrt:MinimumMember\nus-gaap:MeasurementInputPriceVolatilityMember\n\n2026-03-31\n\n0001870404\n\nsrt:MaximumMember\nus-gaap:MeasurementInputPriceVolatilityMember\n\n2026-03-31\n\n0001870404\n\nsrt:MinimumMember\nus-gaap:MeasurementInputRiskFreeInterestRateMember\n\n2026-03-31\n\n0001870404\n\nsrt:MaximumMember\nus-gaap:MeasurementInputRiskFreeInterestRateMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0001870404\n\ncero:SeriesACertificateOfDesignationsMember\n\n2026-03-31\n\n0001870404\n\ncero:SeriesACertificateMember\nus-gaap:SeriesAPreferredStockMember\n\n2026-03-31\n\n0001870404\n\ncero:SeriesAConversionPriceFloorMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:SeriesAConversionPriceFloorMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\nus-gaap:PrivatePlacementMember\n\n2024-02-29\n\n0001870404\n\ncero:FebruaryTwoThousandTwentyFourPIPECommonWarrantsMember\n\n2024-02-29\n\n0001870404\n\nus-gaap:PrivatePlacementMember\n\n2024-02-29\n2024-02-29\n\n0001870404\n\ncero:PromissoryNoteMember\nus-gaap:SeriesAPreferredStockMember\n\n2026-03-31\n\n0001870404\n\ncero:ConvertibleBridgeNotesMember\nus-gaap:SeriesAPreferredStockMember\n\n2026-03-31\n\n0001870404\n\ncero:SeriesAPreferredWarrantsMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\ncero:SeriesAPreferredWarrantsMember\nus-gaap:SeriesAPreferredStockMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:WarrantMember\nus-gaap:SeriesAPreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:WarrantMember\nus-gaap:SeriesAPreferredStockMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\n2024-02-14\n2024-12-31\n\n0001870404\n\nus-gaap:CommonStockMember\n\n2024-12-31\n\n0001870404\n\ncero:SuccessorMember\nus-gaap:SeriesAPreferredStockMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\nus-gaap:PreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\nus-gaap:PreferredStockMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\n\n2025-03-31\n\n0001870404\n\ncero:AlternateConversionMember\nus-gaap:SeriesCPreferredStockMember\n\n2026-03-31\n\n0001870404\n\ncero:SeriesCConversionPriceFloorMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:SuccessorSeriesCConvertiblePreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\nus-gaap:PreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\nus-gaap:PrivatePlacementMember\n\n2024-09-01\n2024-09-30\n\n0001870404\n\ncero:September2024PIPECommonWarrantsMember\n\n2024-09-30\n\n0001870404\n\ncero:September2024PIPECommonWarrantsMember\n\n2024-09-25\n2024-09-25\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\n\n2024-09-25\n2024-09-25\n\n0001870404\n\nus-gaap:InvestorMember\n\n2025-03-10\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\n\n2025-03-10\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\n\n2025-03-10\n2025-03-10\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0001870404\n\ncero:SeriesBCertificateMember\nus-gaap:SeriesBPreferredStockMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\n\n2025-04-22\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\n\n2026-03-31\n\n0001870404\n\ncero:ConversionPriceDebtMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesBPreferredStockMember\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\n\n2025-01-01\n2025-12-31\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\n\n2025-10-14\n2025-10-14\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\n\n2026-03-31\n\n0001870404\n\ncero:SeriesEConversionPriceMember\n\n2026-03-31\n\n0001870404\n\ncero:SuccessorSeriesEConvertiblePreferredStockMember\n\n2026-03-31\n\n0001870404\n\ncero:SuccessorSeriesEConvertiblePreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:BankruptcyTriggeringEventRedemptionRightMember\nus-gaap:SeriesEPreferredStockMember\n\n2025-12-19\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\ncero:FifthSecuritiesPurchaseAgreementMember\n\n2025-10-14\n2025-10-14\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\n\n2025-10-14\n\n0001870404\n\ncero:SuccessorSeriesEConvertiblePreferredStockMember\n\n2025-10-15\n2025-10-15\n\n0001870404\n\ncero:FifthSecuritiesPurchaseAgreementMember\n\n2025-10-15\n2025-10-15\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\ncero:FifthSecuritiesPurchaseAgreementMember\n\n2025-10-16\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\ncero:FifthSecuritiesPurchaseAgreementMember\n\n2025-10-16\n2025-10-16\n\n0001870404\n\nsrt:MinimumMember\ncero:FifthSecuritiesPurchaseAgreementMember\n\n2025-10-16\n\n0001870404\n\nsrt:MaximumMember\ncero:FifthSecuritiesPurchaseAgreementMember\n\n2025-10-16\n\n0001870404\n\n2025-10-16\n2025-10-16\n\n0001870404\n\nus-gaap:SeriesEPreferredStockMember\ncero:FifthSecuritiesPurchaseAgreementMember\n\n2025-12-31\n\n0001870404\n\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-12-31\n\n0001870404\n\nus-gaap:SeriesAPreferredStockMember\nus-gaap:CommonStockMember\n\n2025-12-31\n\n0001870404\n\ncero:SuccessorSeriesEConvertiblePreferredStockMember\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:KeystonePurchaseAgreementMember\n\n2024-02-14\n2024-02-14\n\n0001870404\n\n2024-02-14\n2024-02-14\n\n0001870404\n\ncero:KeystoneELOCMember\n\n2024-02-14\n\n0001870404\n\ncero:KeystonePurchaseAgreementMember\n\n2024-02-14\n\n0001870404\n\ncero:KeystoneELOCMember\n\n2024-11-08\n\n0001870404\n\ncero:KeystoneELOCMember\n\n2024-11-08\n2024-11-08\n\n0001870404\n\nus-gaap:CommonStockMember\n\n2025-07-11\n2025-07-11\n\n0001870404\n\ncero:NewKeystonePurchaseAgreementMember\n\n2025-11-26\n2025-11-26\n\n0001870404\n\ncero:KeystoneELOCMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\ncero:September2024PIPECommonWarrantsMember\n\n2024-01-01\n2024-12-31\n\n0001870404\n\ncero:KeystoneELOCMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:ArenaELOCMember\nus-gaap:CommonStockMember\n\n2025-02-05\n2025-02-05\n\n0001870404\n\nus-gaap:CommonStockMember\n\n2025-02-05\n2025-02-05\n\n0001870404\n\nus-gaap:WarrantMember\n\n2025-02-05\n\n0001870404\n\ncero:SecuritiesPurchaseAgreementMember\n\n2025-02-05\n2025-02-05\n\n0001870404\n\nus-gaap:CommonStockMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:WarrantMember\nus-gaap:CommonStockMember\ncero:SecuritiesPurchaseAgreementMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\ncero:PreFundedWarrantsMember\nus-gaap:CommonStockMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:CommonStockMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:CommonStockMember\ncero:SecuritiesPurchaseAgreementMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:WarrantMember\n\n2025-03-31\n\n0001870404\n\nus-gaap:WarrantMember\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0001870404\n\ncero:JonesTradingInstitutionalServicesMember\n\n2025-02-05\n2025-02-05\n\n0001870404\n\n2025-02-05\n2025-02-05\n\n0001870404\n\nus-gaap:SeriesCPreferredStockMember\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0001870404\n\ncero:PublicAndPrivatePlacementWarrantsMember\n\n2026-03-31\n\n0001870404\n\ncero:CommonFebruary2024PIPEWarrantsMember\n\n2026-03-31\n\n0001870404\n\ncero:CommonSeptember2024PIPEWarrantsMember\n\n2026-03-31\n\n0001870404\n\ncero:CommonDecember2024InducementMember\n\n2026-03-31\n\n0001870404\n\ncero:JanuaryTwoThousandTwentyFiveWarrantsMember\n\n2026-03-31\n\n0001870404\n\ncero:FebruaryTwoThousandTwentyFivePreFundedWarrantsMember\n\n2026-03-31\n\n0001870404\n\ncero:FebruaryTwoThousandTwentyFiveCommonWarrantsMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel1Member\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel2Member\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel3Member\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel1Member\n\n2024-12-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel2Member\n\n2024-12-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel3Member\n\n2024-12-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel1Member\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel2Member\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel3Member\n\n2025-01-01\n2025-03-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel1Member\n\n2025-03-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel2Member\n\n2025-03-31\n\n0001870404\n\nus-gaap:FairValueInputsLevel3Member\n\n2025-03-31\n\n0001870404\n\ncero:TwoThousandTwentyFourPlanMember\nus-gaap:CommonStockMember\n\n2024-03-25\n\n0001870404\n\ncero:TwoThousandTwentyFourPlanMember\n\n2024-04-30\n2024-04-30\n\n0001870404\n\ncero:TwoThousandTwentyFourPlanMember\n\n2024-11-11\n2024-11-11\n\n0001870404\n\ncero:TwoThousandTwentyFourPlanMember\n\n2025-01-01\n2025-01-01\n\n0001870404\n\ncero:TwoThousandTwentyFourPlanMember\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-01-01\n\n0001870404\n\ncero:TwoThousandTwentyFourPlanMember\nus-gaap:CommonStockMember\n\n2025-05-29\n2025-05-29\n\n0001870404\n\ncero:TwoThousandTwentyFourPlanMember\nus-gaap:CommonStockMember\nus-gaap:EmployeeStockMember\n\n2025-12-19\n2025-12-19\n\n0001870404\n\n2025-12-19\n2025-12-19\n\n0001870404\n\nus-gaap:CommonStockMember\n\n2025-12-19\n\n0001870404\n\nsrt:BoardOfDirectorsChairmanMember\n\n2026-01-07\n2026-01-07\n\n0001870404\n\nsrt:BoardOfDirectorsChairmanMember\n\n2026-01-07\n\n0001870404\n\n2026-03-04\n2026-03-04\n\n0001870404\n\nsrt:BoardOfDirectorsChairmanMember\n\n2026-03-04\n2026-03-04\n\n0001870404\n\n2026-03-04\n\n0001870404\n\nus-gaap:OptionMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nus-gaap:OptionMember\n\n2026-03-31\n\n0001870404\n\ncero:PredecessorMember\n\n2026-03-31\n\n0001870404\n\nsrt:MaximumMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nsrt:MinimumMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nsrt:BoardOfDirectorsChairmanMember\n\n2025-02-05\n2025-02-05\n\n0001870404\n\nsrt:BoardOfDirectorsChairmanMember\ncero:PreFundedWarrantsMember\n\n2025-02-05\n\n0001870404\n\nsrt:BoardOfDirectorsChairmanMember\ncero:CommonFebruary2025PIPEWarrantsMember\n\n2025-02-05\n\n0001870404\n\ncero:FourthPIPEFinancingMember\nus-gaap:SeriesDPreferredStockMember\n\n2025-04-22\n\n0001870404\n\ncero:FourthPIPEFinancingMember\nus-gaap:SeriesDPreferredStockMember\nus-gaap:PreferredStockMember\n\n2025-04-22\n\n0001870404\n\nsrt:BoardOfDirectorsChairmanMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\nsrt:BoardOfDirectorsChairmanMember\n\n2025-01-01\n2025-03-31\n\n0001870404\n\ncero:AtwoodEdminsterTrustDtd422000AndGVNLLCMember\nus-gaap:SeriesAPreferredStockMember\n\n2026-03-31\n\n0001870404\n\ncero:AtwoodEdminsterTrustDtd422000AndGVNLLCMember\nus-gaap:SeriesAPreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001870404\n\ncero:PreFundedWarrantsAndFebruary2025CommonWarrantsMember\ncero:AtwoodEdminsterTrustDtd422000AndGVNLLCMember\n\n2026-03-31\n\n0001870404\n\nus-gaap:SubsequentEventMember\n\n2026-04-01\n2026-05-14\n\n0001870404\n\nus-gaap:SubsequentEventMember\n\n2026-05-14\n\n0001870404\n\ncero:ConvertiblePromissoryNoteMember\nus-gaap:SubsequentEventMember\n\n2026-04-08\n\n0001870404\n\ncero:MarchTwoThousandTwentySixMember\nus-gaap:SubsequentEventMember\n\n2026-04-08\n\n0001870404\n\nsrt:ScenarioForecastMember\ncero:FebruaryTwoThousandTwentySixMember\n\n2026-04-30\n\n0001870404\n\nsrt:ScenarioForecastMember\n\n2027-04-09\n\n0001870404\n\nsrt:ScenarioForecastMember\ncero:ConvertiblePromissoryNoteMember\n\n2027-04-09\n\n0001870404\n\ncero:ConvertiblePromissoryNoteMember\nus-gaap:SubsequentEventMember\n\n2026-04-27\n\n0001870404\n\nus-gaap:SubsequentEventMember\ncero:NewKeystonePurchaseAgreementMember\n\n2026-04-27\n\n0001870404\n\ncero:FebruaryTwoThousandTwentySixMember\nus-gaap:SubsequentEventMember\n\n2026-04-27\n\n0001870404\n\ncero:ConvertiblePromissoryNoteMember\nus-gaap:SubsequentEventMember\n\n2026-04-27\n2026-04-27\n\n0001870404\n\nus-gaap:SubsequentEventMember\n\n2026-04-27\n\n0001870404\n\nus-gaap:SubsequentEventMember\n\n2026-04-27\n2026-04-27\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\nus-gaap:SubsequentEventMember\n\n2026-05-05\n2026-05-05\n\n0001870404\n\nus-gaap:SeriesDPreferredStockMember\nus-gaap:CommonStockMember\nus-gaap:SubsequentEventMember\n\n2026-05-05\n2026-05-05\n\n0001870404\n\nus-gaap:CommonStockMember\nus-gaap:SubsequentEventMember\n\n2026-05-05\n\n0001870404\n\ncero:SeriesEPreferredSharesMember\nus-gaap:SubsequentEventMember\n\n2026-05-05\n\n0001870404\n\ncero:SeriesEPreferredSharesMember\nus-gaap:SubsequentEventMember\n\n2026-05-05\n2026-05-05\n\nxbrli:shares\n\niso4217:USD\n\niso4217:USD\n\nxbrli:shares\n\nxbrli:pure\n\ncero:Segments"}